|
Parameters
|
IGT group (n = 108)
|
Control group (n = 84)
|
P value
|
|---|
|
Sex (M/F)
|
65/43
|
44/40
|
0.279
|
|
Age (years)
|
57.31 ± 7.21
|
56.83 ± 7.55
|
0.651
|
|
BMI (kg/m2)
|
26.43 ± 4.83
|
24.26 ± 3.44
|
0.001
|
|
SBP (mmHg)
|
128.11 ± 6.86
|
126.46 ± 6.89
|
0.101
|
|
DBP (mmHg)
|
75.62 ± 6.50
|
74.14 ± 7.38
|
0.142
|
|
TC (mmol/L)
|
5.15 ± 1.06
|
4.92 ± 0.91
|
0.109
|
|
HDL-C (mmol/L)
|
1.34 ± 0.27
|
1.58 ± 0.37
|
<0.001
|
|
LDL-C (mmol/L)
|
3.10 ± 0.74
|
2.85 ± 0.75
|
0.024
|
|
TG (mmol/L)
|
2.37 (1.99, 2.79)
|
1.09 (0.71, 1.48)
|
<0.001
|
|
ApoA-I (g/L)
|
1.37 ± 0.36
|
1.57 ± 0.39
|
<0.001
|
|
ApoB (g/L)
|
0.97 ± 0.22
|
0.90 ± 0.23
|
0.030
|
|
ApoA-I/HDL-C
|
0.99 (0.91, 1.10)
|
0.99 (0.85, 1.11)
|
0.821
|
|
FBG (mmol/L)
|
6.30 (5.60, 6.98)
|
5.58 (5.24, 5.82)
|
<0.001
|
|
2hPG (mmol/L)
|
9.30 (8.63, 9.80)
|
6.50 (6.08, 6.73)
|
<0.001
|
|
HbA1c (%)
|
6.30 (6.00, 6.40)
|
5.90 (5.60, 6.10)
|
<0.001
|
|
FINS (mIU/L)
|
15.70 (10.80, 18.30)
|
8.17 (5.39, 11.97)
|
<0.001
|
|
HOMA-IR
|
4.21 ± 1.56
|
2.15 ± 0.99
|
<0.001
|
- IGT group, patientswith impaired glucose tolerance; Control group, control subjects; BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TG triglycerides, apoA-I apolipoprotein A-I, apoB apolipoprotein B, FBG fasting blood glucose, 2hPG 2-h postchallenge glucose, HbA1c glycated hemoglobin, FINS fasting insulin, HOMA-IR homeostasis model assessment of insulin resistance
